CDC
Listen: Dr. Arjun Srinivasan from the CDC and Dr. Kevin Kavanagh from HW USA discuss healthcare acquired infections
link to Dr Arjun Srinivasan’s radio presentation April 23, 2013 on 590 AM WVLK
Categories: Hospital Acquired Infections
Tags: CDC, Health Watch USA
Health Watch USA Newsletter (April 22, 2013)
Patient safety news collected by Health Watch USA.. Hospital Acquired Infections Radio Show with Arjun Srinivasan from the CDC and Dr. Kevin Kavanagh, Board Director of Health Watch USA.
Categories: Hospital Acquired Infections
Tags: CDC, CRE, external, Health Watch USA
NHSN Validation Guidance and Toolkit; Validation for 2012 Central Line-associated Bloodstream Infection (CLABSI) in ICUs
CDC validation tool kit for ICU central line-associated bloodstream infections now officially public
Categories: Hospital Acquired Infections
Tags: CDC, CLABSIs, external, NHSN, validation
CDC report: 2011 National and State Healthcare-associated Infections Standardized Infection Ratio Report
CDC reported for 2011: A 41 percent reduction in central line-associated bloodstream infections since 2008; a 17 percent reduction in surgical site infections since 2008; a 7 percent reduction in catheter-associated urinary tract infections since 2009
Categories: Hospital Acquired Infections
Tags: CDC, external, SIR, Standardized Infection Ratio
Consumer Reports: Deadly infections still too common in U.S. hospitals
The number of potentially deadly infections picked up by patients in hospitals is down slightly, according to a new report from the Centers for Disease Control and Prevention. But your risk still depends on which hospital you go to, since the rate of infections varies widely, with some hospitals reporting none of them and others reporting many.
Categories: Hospital Acquired Infections
Tags: CDC, Consumer Reports
Consumer Reports: Meningitis cases from tainted steroids continue to rise
The outbreak of fungal meningitis due to a contaminated steroid has affected 490 people and caused 34 deaths, according to updated figures released earlier this week from the Centers for Disease Control and Prevention. (Update: As of Nov., 27, the CDC reports the number of people affected has increased to 510 and caused 36 deaths.)
Categories: Hospital Acquired Infections, Medical Devices & Drugs
Tags: CDC, Consumer Reports
Report faults states’ oversight of specialty pharmacies
State boards have failed to adequately regulate the safety of practices at specialty pharmacies like the one at the center of the deadly fungal meningitis outbreak, according to a congressional report to be released Monday.
Categories: Hospital Acquired Infections, Medical Devices & Drugs
Tags: CDC, Meningitis
FDA Statement on Fungal Meningitis Outbreak: Additional Patient Notification Advised
[Update 10/18/2012] CDC and FDA have confirmed the presence of a fungus known as Exserohilum rostratum in unopened medication vials of preservative-free methylprednisolone acetate (80mg/ml) from one of the three implicated lots from NECC (Lot #08102012@51, BUD 2/6/2013). The laboratory confirmation further links steroid injections from these lots from NECC to the multistate outbreak of fungal meningitis and joint infections. Testing on the other two implicated lots of methylprednisolone acetate and other NECC injectables continues.
Categories: Hospital Acquired Infections, Medical Devices & Drugs
Tags: CDC, FDA, Meningitis
2 die in meningitis outbreak; Saint Thomas neurosurgery clinic shuts down
The Tennessee Department of Health is joining forces with the Center for Disease Control to investigate an unusual outbreak of meningitis that has hit 11 Tennesseans so far, killing two of them.
Categories: Hospital Acquired Infections, Medical Devices & Drugs
Tags: CDC, Meningitis
Frequently Asked Questions For Patients: Multistate Meningitis Outbreak Investigation
CDC link on advice to patients
Categories: Hospital Acquired Infections, Medical Devices & Drugs
Tags: CDC, external, Meningitis
The Safe Patient Project is a Consumers Union campaign focused on eliminating medical harm, improving FDA oversight of prescription drugs and promoting disclosure laws that give information to consumers about health care safety and quality.